Alpha Cognition Inc. Increase (Decrease) in Inventories
Alpha Cognition Inc. (ACOG) reported Increase (Decrease) in Inventories of $1.27 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-13
- Alpha Cognition Inc. increase (decrease) in inventories for the quarter ending 2026-06-30 was $351.10K.
- Alpha Cognition Inc. increase (decrease) in inventories for the quarter ending 2026-03-31 was $920.22K, a 243.05% increase year-over-year.
- Alpha Cognition Inc. increase (decrease) in inventories for the quarter ending 2025-12-31 was $624.13K.
- Alpha Cognition Inc. increase (decrease) in inventories for the quarter ending 2025-09-30 was $3.62M.
- Alpha Cognition Inc. increase (decrease) in inventories for fiscal 2025 was $4.51M, a 632.91% increase from fiscal 2024.
- Alpha Cognition Inc. increase (decrease) in inventories for fiscal 2024 was $615.13K.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | $351.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.27M 10-Q · filed 2026-08-13 | $1.90M derived: sum of 3 quarters · filed 2026-08-13 | $5.52M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $920.22K 10-Q · filed 2026-05-14 | $1.54M derived: sum of 2 quarters · filed 2026-05-14 | $5.17M derived: sum of 3 quarters · filed 2026-05-14 | $5.16M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $624.13K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $4.25M derived: sum of 2 quarters · filed 2026-03-31 | $4.24M derived: sum of 3 quarters · filed 2026-08-13 | $4.51M 10-K · filed 2026-03-31 |
| 2025-09-30 | $3.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $3.62M derived: sum of 2 quarters · filed 2026-08-13 | $3.88M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$7.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $260.72K 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | $268.24K 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | $615.13K 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |